View Older Stories View More Recent Stories
-
Red Light Holland shareholders approve name change, CFO resigns
-
Red Light Holland Announces Shareholder Approval of Name Change and Announces Voting Results from 2026 Annual General and Special Meeting of Shareholders
-
Red Light Holland Highlights Publication of Randomized Clinical Trial Showing a Single Dose of Psilocybin Reduced Cocaine Use, with Filament Health Holding the Exclusive License to the Data and Intell
-
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Expands Distribution of PEX010 Across Canadian and U.S. Research Institutions
-
Red Light Holland Announces Intention to Rebrand
-
Red Light Holland completes acquisition of Filament Health
-
Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution
-
Red Light Holland Announces Filament Health Obtains Final Order for Proposed Arrangement
-
Red Light Holland Announces Filament Health Shareholder Approval of Acquisition
-
Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments
-
Red Light Holland Highlights U.S. FDA-Authorized Study Supporting Multi-Session Psilocybin Therapy using Filament Health's Patented PEX010 Botanical Drug Candidate
-
Red Light Holland Reports Continued Expansion of Filament Health's PEX010 Clinical Network with New License Agreements and Research Shipments
-
Red Light Holland to Support University of California San Francisco's Global Psychedelic Study Through Filament Health's Clinical Network
-
Red Light Holland Announces Filament Health Obtains Interim Order for Proposed Arrangement
-
Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate
-
Red Light Holland to acquire Filament Health in all-share deal
-
RETRANSMISSION: Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation
-
Red Light Holland to acquire Filament Health in all-share deal
-
Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation
-
Red Light Holland Reports Third Quarter 2026 Results and Provides Corporate Update
-
Red Light Holland Reports Second Quarter 2026 Results and Provides Corporate Update
-
Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Receives Second, Larger 5kg Psilocybin Shipment via USA Controlled Substances Import Permit
-
Red Light Holland's Wholly Owned Subsidiary Happy Caps Expands Safeway Partnership to 123 Stores Across the U.S. Pacific Northwest, in Time for American Thanksgiving
-
Red Light Holland Secures Second United States Controlled Substances Import Permit for the Company's Psilocybin Through FDA-Compliant, DEA-Registered Partner Irvine Labs
-
Red Light Holland Receives Official Psilocybin COA Through FDA-Compliant, DEA-Registered Partner, Irvine Labs, USA
-
Red Light Holland's Wholly Owned Subsidiary Happy Caps Mushroom Farm Secures Continued Safeway Partnership to 123 Stores Across Two Seasonal Programs in the U.S.
-
Red Light Holland Reports First Quarter 2026 Results
-
Red Light Holland Updates Bitcoin Balance Sheet Strategy
-
Red Light Holland Applauds HHS Review of Psilocybin Rescheduling Petition, Expresses Optimism for Reversal of Schedule I Classification
-
Red Light Holland Receives Initial Third-Party Psilocybin Testing Results via FDA-Compliant, DEA-Registered Partner, Irvine Labs
-
Red Light Holland CEO Todd Shapiro Invited by Blockchain Futurist Conference for Fireside Chat and Panel Hosting
-
Red Light Holland Reports 2025 Audited Year-End Results - Demonstrates Continued Fiscal Discipline, Strategic Growth, and Psilocybin R&D Expansion
-
Red Light Holland Provides Timing for 2025 Audited Year-End Results and Announces Live Q&A
-
Red Light Holland Selects Arch Public for Bitcoin Purchases on Recommendation from Advisor Scott Melker
-
Red Light Holland Announces Bitcoin Balance Sheet Strategy and Names Scott Melker as Lead Cryptocurrency Advisor
-
Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Receives First Global Shipment of Psilocybin from Company's Netherlands Facility via USA Controlled Substances Permit
-
Red Light Holland Announces Dr. Robin Carhart-Harris as Scientific Advisor
-
Red Light Holland Partners with Arizona State University to Support Groundbreaking Psychedelic Genome Project (PGP) Research Study
-
Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Granted United States Controlled Substances Import Permit for the Company's Raw Psilocybin Truffles
-
Red Light Holland Announces Happy Caps 2kg "Mega Block" Mushroom Home Grow Kits Are Now Available in Costco Stores Across Canada
-
Red Light Holland's Wholly Owned Subsidiary Happy Caps Launches Presales of Health Canada Approved Functional Mushroom Gummies
-
Red Light Holland's Wholly Owned Subsidiary Happy Caps Mushroom Farm Officially Launches with Albertsons - 66 Safeway Stores Across Oregon and Washington, United States
-
Red Light Holland's Partner FDA-Compliant and DEA-Registered Irvine Labs Receives 2025 Psilocybin DEA Quotas, Including Import Quota
-
Red Light Holland's Wholly Owned Subsidiary Happy Caps Mushroom Farm Secures Purchase Order with Albertsons - Safeway for First U.S. Retail Launch
-
Red Light Holland Appoints Michael Galloro to Board of Directors
-
Red Light Holland Announces Costco Canada Signals Another Expanded Commitment to Happy Caps Mushroom Home Grow Kits
-
Red Light Holland Reports Third Quarter 2025 Results
-
Red Light Holland's Wholly Owned Subsidiary Happy Caps Receives Health Canada Approval For, Unique Mushroom Gummy Formula, Functional Mushroom Gummies
-
Red Light Holland, in Partnership with FDA-Compliant and DEA-Registered Irvine Labs, Updates R&D Plan Focused On Commercialization
-
Red Light Holland Appoints Keith Li as Chief Financial Officer and Provides Corporate Updates
